Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications

Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications

US Patent 7138413 · Granted Nov 21, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2024
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2024
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2024
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2024
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2022
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2022
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2022
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2022
Therapeutical use of H3-ligands2021
Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical composi2021
Combination of adrenalin with an antidepressant for use in the treatment of shoc2021
Combination of adrenalin with an antidepressant for use in the treatment of shoc2021